A 20 percent sugary drink tax would cut number of UK obese adults by 180,000

October 31, 2013

A 20% tax on sugar sweetened drinks would reduce the number of UK adults who are obese by 180,000 (1.3%) and who are overweight by 285,000 (0.9%), suggests a study published on bmj.com today.

Although this is a relatively modest effect, people aged 16-29 years, as the major consumers of sugar sweetened drinks, would be impacted the most, say the authors.

Regular consumption of sugar sweetened drinks increases the risk of obesity, diabetes, and tooth decay. The idea of a sugar sweetened drink tax as one way to reduce consumption and raise revenue is gaining traction in the UK, but its effect on health remains uncertain.

So researchers at the universities of Oxford and Reading set out to estimate the effect of a 20% tax on sugar sweetened drinks on obesity in the UK - and to understand the health effect on different income groups.

Using data from surveys of dietary purchases, the price of drinks, and body weight, they estimate that a 20% sales tax on sugar sweetened drinks would reduce the number of obese adults in the UK by 180,000 (1.3%) and the number who are overweight by 285,000 (0.9%).

The health gains would be similar across all income groups, but would decline with age. As the major consumers of sugar sweetened drinks, young people (under the age of 30 years) would experience the greatest reductions in obesity.

The tax would be expected to raise £276m (€326m; $442m) annually (around 8p per person per week) and would reduce consumption of sugar sweetened drinks by around 15%.

This revenue, say the authors, "could be used to increase NHS funding during a period of budget restrictions or to subsidise foods with health benefits, such as fruit and vegetables."

They conclude that taxation of sugar sweetened drinks "is a promising population measure to target population obesity, particularly among younger adults." But they stress that it "should not be seen as a panacea" and say further work is needed to clarify the level (and patterns) of sugar sweetened drink consumption in the UK.

In an accompanying editorial, Jason Block, Assistant Professor at Harvard Medical School in the US, says this study provides evidence that a 20% tax on sugary drinks can work - and he calls on more countries "to implement high taxes and measure the results."

A proposal by the Academy of Medical Royal Colleges calling for the UK to pilot and monitor the effect of a one year 20% tax on sugary drinks "would be a good start," he says.

"Econometric modelling studies are important and helpful but provide projections rather than measures after actual policy change. We now need policy makers to act and provide opportunities for real world evidence on a 20% tax on sugar sweetened drinks," he concludes.
-end-
Research: Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study

Editorial: A substantial tax on sugar sweetened drinks could help reduce obesity

BMJ

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.